公开(公告)号：US20230212687A1

公开(公告)日：2023-07-06

申请号：US17988959

申请日：2022-11-17

申请人： TORAY INDUSTRIES, INC. ,  NATIONAL CANCER CENTER

发明人： Makiko YOSHIMOTO ,  Hiroko SUDO ,  Atsuko MIYANO ,  Satoko KOZONO ,  Takahiro OCHIYA ,  Hiroyuki FUJIMOTO ,  Fumihiko URABE ,  Juntaro MATSUZAKI

IPC分类号： C12Q1/6886

CPC分类号： C12Q1/6886 ,  C12Q2600/158 ,  C12Q2600/178

摘要： This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.

公开(公告)号：US20240141439A1

公开(公告)日：2024-05-02

申请号：US18408056

申请日：2024-01-09

申请人： TORAY INDUSTRIES, INC. ,  NATIONAL CANCER CENTER

发明人： Makiko YOSHIMOTO ,  Hiroko SUDO ,  Atsuko MIYANO ,  Satoko KOZONO ,  Takahiro OCHIYA ,  Hiroyuki FUJIMOTO ,  Fumihiko URABE ,  Juntaro MATSUZAKI

IPC分类号： C12Q1/6886

CPC分类号： C12Q1/6886 ,  C12Q2600/158 ,  C12Q2600/178

摘要： This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.

公开(公告)号：US20210310077A1

公开(公告)日：2021-10-07

申请号：US17265060

申请日：2019-08-09

申请人： TORAY INDUSTRIES, INC. ,  NATIONAL CANCER CENTER

发明人： Makiko YOSHIMOTO ,  Hiroko SUDO ,  Atsuko MIYANO ,  Satoko KOZONO ,  Takahiro OCHIYA ,  Hiroyuki FUJIMOTO ,  Fumihiko URABE ,  Juntaro MATSUZAKI

IPC分类号： C12Q1/6886

摘要： This invention provides a kit or device for detection of prostate cancer and a method for detecting prostate cancer. This invention provides a kit or device for detection of prostate cancer comprising a nucleic acid capable of specifically binding to an miRNA in a sample from a subject or a complementary strand thereof and a method for detecting prostate cancer comprising measuring the miRNA in vitro.